Novel coronavirus (SARS-CoV-2) enters its host cell through a surface spike protein. The
viral spike protein has undergone several modifications/mutations at the genomic level …

The global coronavirus disease 2019 (COVID‐19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has led to an unprecedented worldwide …

The COVID-19 (coronavirus disease 2019) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has led to loss of human life in millions and …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has recently emerged
in China and caused a disease called coronavirus disease 2019 (COVID-19). The virus …

The recent release of SARS-CoV-2 genomic data from several countries has provided clues
into the potential antigenic drift of the coronavirus population. In particular, the genomic …

Three coronaviruses (CoVs) have threatened the world population by causing outbreaks in
the last two decades. In late 2019, the severe acute respiratory syndrome coronavirus-2 …

There are no approved target therapeutics against SARS-CoV-2 or other beta-CoVs. The
beta-CoV Spike protein is a promising target considering the critical role in viral infection …

The spike protein (S-protein) of SARS-CoV-2, the protein that enables the virus to infect
human cells, is the basis for many vaccines and a hotspot of concerning virus evolution …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causative agent of the
coronavirus disease-2019 (COVID-19) has resulted in several deaths and severe economic …

In December 2019, a novel coronavirus, termed severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was identified as the cause of pneumonia with severe …